Search results
Showing 496 to 510 of 1688 results for carers
This guideline covers needle and syringe programmes for people (including those under 16) who inject drugs. The main aim is to reduce the transmission of viruses and other infections caused by sharing injecting equipment, such as HIV, hepatitis B and C. In turn, this will reduce the prevalence of blood-borne viruses and bacterial infections, so benefiting wider society.
hospital to home or the community, including the effects on formal and informal carers, and on avoidable readmissions? Any explanatory...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
Evidence-based recommendations on PeritX for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites.
and North Hertfordshire NHS Trust has recently implemented a continuity of carer pathway for women with multiple pregnancies to meet the...
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome
In development [GID-DG10074] Expected publication date: 19 December 2024
In development [GID-TA10907] Expected publication date: 30 April 2025
This quality standard covers the effective use of antimicrobial medicines (including antibiotics) to reduce the risk of antimicrobial resistance, which is when antimicrobial medicines lose their effectiveness. It covers all settings and all types of antimicrobials for treating bacterial, fungal, viral and parasitic infections. It describes high-quality care in priority areas for improvement.
View quality statements for QS121Show all sections
Sections for QS121
- Quality statements
- Quality statement 1: Advice on self-limiting conditions
- Quality statement 2: Back-up (delayed) prescribing
- Quality statement 3: Recording information
- Quality statement 4: Microbiological samples
- Quality statement 5: Data collection and feedback
- Quality statement 6 (developmental statement): electronic prescribing systems
- Update information
This indicator covers the percentage of patients with diabetes who have a record of a dietary review by a suitably competent professional in the preceding 15 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM28
Ruxolitinib for treating non-segmental vitiligo in people 12 years and over [ID3998]
In development [GID-TA10893] Expected publication date: TBC
Interim methods guide for developing good practice guidance (PMG15)
Interim methods guide for developing good practice guidance
In development [GID-HTE10047] Expected publication date: 19 December 2024
Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013
permanency (incorporating the perspectives of lookedafter children and permanency carers)? Any explanatory notes(if applicable) For a...
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis